Patterns of Care of Cancers and Radiotherapy in Ethiopia.
Journal
Journal of global oncology
ISSN: 2378-9506
Titre abrégé: J Glob Oncol
Pays: United States
ID NLM: 101674751
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
entrez:
14
12
2019
pubmed:
14
12
2019
medline:
22
5
2020
Statut:
ppublish
Résumé
Radiotherapy (RT) is an essential component of cancer treatment. There is a lack of RT services in sub-Saharan Africa as well as limited knowledge regarding clinical practices. The purpose of this study was to identify and describe the patterns for RT treatment in Ethiopia. We performed a retrospective analysis of 1,823 patients treated with cobalt RT at a large referral hospital in Addis Ababa, Ethiopia, from May 2015 through January 2018. Paper charts were reviewed for patient and treatment characteristics. Descriptive statistics were computed using SPSS (IBM, Armonk, NY). Among patients treated for cancer, 98% (n = 1,784) were adults, 78% (n = 1,426) were female, 5% (n = 85) were HIV positive, 30% (n = 555) were from Addis Ababa, and the median age was 48 years (interquartile range [IQR], 38-58 years). Cervical cancer was the most frequent cancer treated (47%, n = 851), followed by breast cancer (15%, n = 274) and head and neck cancer (10%, n = 184). Seventy-three percent of patients (n = 1,339) presented at a late stage, and 62% (n = 1,138) received palliative RT. The wait times were the shortest for patients receiving palliative treatment (median, 0 days; IQR, 0-15 days; n = 1,138), whereas wait times were longer for patients receiving curative treatment (median, 150 days; IQR, 60-210 days; n = 685). Three percent of patients (n = 56) had documented grade 3 or 4 acute toxicity; of these, 59% (n = 33) were patients with head and neck cancer. Cervical cancer accounted for half of patients treated; thus, a majority of patients were adult females. Most patients had advanced-stage cancer, and goals of care were palliative. Wait times were long for patients with curative-intent cancer as a result of low capacity for RT services.
Identifiants
pubmed: 31834831
doi: 10.1200/JGO.19.00129
pmc: PMC6939739
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-8Subventions
Organisme : NCI NIH HHS
ID : K08 CA230170
Pays : United States
Références
Oncologist. 2018 Sep;23(9):1024-1032
pubmed: 29567823
Int J Gynecol Cancer. 2015 Jun;25(5):884-90
pubmed: 25853380
Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):201-210
pubmed: 29619965
J Glob Oncol. 2018 Sep;4:1-10
pubmed: 30241139
Lancet Oncol. 2013 Oct;14(11):1086-1094
pubmed: 24055415
Prev Chronic Dis. 2012;9:E84
pubmed: 22498035
Lancet Oncol. 2006 Jul;7(7):584-95
pubmed: 16814210
Lancet Oncol. 2013 Apr;14(4):e168-75
pubmed: 23561748
Ann Oncol. 2011 Dec;22(12):2675-86
pubmed: 21471563
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
J Glob Oncol. 2018 Sep;4:1-11
pubmed: 30241262
Lancet Glob Health. 2016 Dec;4(12):e923-e935
pubmed: 27855871
Lancet. 2017 Feb 25;389(10071):847-860
pubmed: 27814965
BMC Res Notes. 2015 Dec 12;8:772
pubmed: 26654449
Cancer Epidemiol. 2018 Apr;53:93-98
pubmed: 29414637
Nat Rev Clin Oncol. 2014 May;11(5):251-9
pubmed: 24614139
Oncologist. 2014 Jul;19(7):727-34
pubmed: 24951611
Oral Oncol. 2014 Apr;50(4):282-90
pubmed: 24405882
Glob Health Action. 2014 Oct 29;7:25550
pubmed: 25377338
Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):929-36
pubmed: 11958885
Clin Oncol (R Coll Radiol). 2015 Feb;27(2):107-14
pubmed: 25455407
Pan Afr Med J. 2018 Aug 06;30:248
pubmed: 30627309
Radiother Oncol. 2004 Jun;71(3):347-55
pubmed: 15172152
Radiother Oncol. 2003 Mar;66(3):253-62
pubmed: 12742264